Molecular pathogenesis of primary hyperparathyroidism
F. Cetani, E. Pardi, S. Borsari, and C. Marcocci
Department of Endocrinology and Metabolism, University of Pisa, Pisa, Italy
Primary hyperparathyroidism (PHPT) is a common endocrinopathy, mostly caused by a monoclonal parathyroid adenoma. The hereditary syndromes include multiple endocrine neoplasia types 1 (MEN 1) and 2A (MEN 2A), hereditary hyperparathyroidism-jaw tumor (HPTJT), familial isolated hyperparathyroidism (FIHP), familial hypocalciuric hypercalcemia (FHH) and neonatal severe hyperparathyroidism (NSHPT). Mutations of MEN1 and CDKN1B genes are responsible for MEN 1 in 70-80% and about 2% of cases, respectively. MEN1 and CDKN1B genes have also a role in the pathogenesis of sporadic parathyroid adenomas. HRPT2/CDC73 gene mutations are responsible for HPT-JT and sporadic parathyroid carcinoma. MEN1 and HRPT2/CDC73 genes mutations have also been found in a subset of FIHP families. FHH and NSHPT represent the mildest and severest variants of PHPT, caused by heterozygous and homozygous mutations in the calcium sensing receptor (CASR) gene, respectively. [J. Endocrinol. Invest. 34 (Suppl. to no. 7): 35-39, 2011] ©2011, Editrice Kurtis
![]() |
|
| Problem with log in? | |
|
◊ lost password ◊ register for free |
|
| » General information » Editorial board » Editorial staff » Instructions for authors » Previews » Current issue » Previous issues » Special issues » Subscription » Versione italiana ![]() |